Related Funds
Funds with similar focus
Fund Name | Location |
Air Products and Chemicals | Kelayres, Pennsylvania, United States |
Alsessor | - |
Beiguang Wenzi Gehua | Beijing, Beijing, China |
BNOTIONS | Canada, Ontario, Toronto |
CAS Investment Management | Beijing, Beijing, China |
Connected VC | New York, New York, United States |
Grafton Capital | England, London, United Kingdom |
HUB612 | France, Lyon, Rhone-Alpes |
IngDan International | China, Guangdong, Shenzhen |
MMC Capital Communications & Information Fund | Connecticut, Greenwich, United States |
N Capital Partners | - |
NextGen Ventures | Gelderland, Lunteren, The Netherlands |
Panming Investment | China, Shanghai |
Paul Wurth InCub | Luxembourg, Luxembourg |
Polish Agency for Enterprise Development | Mazowieckie, Poland, Warszawa |
Ramen Underground | - |
Taylor Farms | California, Salinas, United States |
Yongxin Xianta Luosi Qiye Guanli Zhongxin | China, Jian, Jiangxi |
Yunfeng Touzi | China, Hangzhou, Zhejiang |
Zimmerman Ventures | Milwaukee, United States, Wisconsin |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Chengdu Pukang Biotechnology Co. | 06 Jun 2024 | Chengdu, Sichuan, China | |||
Diallebo | $15M | 15 Sep 2023 | Zhangjiagang, Jiangsu, China | ||
Eaglenos | $23M | 29 May 2023 | Nanjing, Jiangsu, China | ||
Kingdee Invoice Cloud | 18 May 2023 | Shenzhen, Guangdong, China | |||
YunLSP | $15M | 06 Jun 2022 | Gusu District, Jiangsu, China | ||
Yaotan Pharmaceutical | $29M | 29 Mar 2022 | Shanghai, Shanghai, China | ||
Vision Semiconductor Technology | $15M | 29 Nov 2021 | Nanjing, Jiangsu, China | ||
10 Mar 2021 | Shanghai, China | ||||
InxMed | $20M | 04 Sep 2020 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Chengdu Pukang Biotechnology Co. | 06 Jun 2024 | Chengdu, Sichuan, China | |||
Diallebo | $15M | 15 Sep 2023 | Zhangjiagang, Jiangsu, China | ||
Eaglenos | $23M | 29 May 2023 | Nanjing, Jiangsu, China | ||
Kingdee Invoice Cloud | 18 May 2023 | Shenzhen, Guangdong, China | |||
YunLSP | $15M | 06 Jun 2022 | Gusu District, Jiangsu, China | ||
Yaotan Pharmaceutical | $29M | 29 Mar 2022 | Shanghai, Shanghai, China | ||
Vision Semiconductor Technology | $15M | 29 Nov 2021 | Nanjing, Jiangsu, China | ||
10 Mar 2021 | Shanghai, China | ||||
InxMed | $20M | 04 Sep 2020 | Shanghai, China |